Related Experiment Video
Updated: Aug 13, 2026
10:44
Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Roles of cytochrome p450 in development
I Stoilov1, I Jansson, M Sarfarazi
1Department of Pharmacology, University of Connecticut Health Center, Farmington 06030, USA.
Drug Metabolism and Drug Interactions
|August 28, 2001
Summary
Cytochrome P450 (CYP) enzymes, conserved across species, may metabolize endogenous molecules to support embryonic development and morphogenesis. These enzymes are crucial for regulating morphogen activity during tissue differentiation.
Area of Science:
- Biochemistry
- Developmental Biology
- Molecular Biology
Background:
- Cytochrome P450 (CYP) enzymes are highly conserved across species, with significant sequence identity among homologous forms.
- Many CYP forms are present in embryonic tissues and exhibit temporal dependence.
- The ancient evolutionary origin of xenobiotic metabolizing enzymes suggests potential roles in metabolizing endogenous substrates.
Purpose of the Study:
- To explore the potential role of embryonic Cytochrome P450 forms in supporting embryonic tissue morphogenesis.
- To investigate whether CYP enzymes function in generating or eliminating morphogenic molecules, thereby regulating spatial and temporal morphogen action.
- To examine the involvement of specific CYP forms, such as CYP26 and CYP1B1, in embryonic development and tissue differentiation.
Main Methods:
- Comparative analysis of CYP sequences and activities across species.
- Review of literature on known morphogens and their metabolic regulation.
- Case studies of specific CYP forms (CYP26, CYP1B1) in relation to embryonic development and disease.
Main Results:
- High sequence and functional conservation of CYP forms across diverse species suggest conserved functions.
- CYP26 plays a role in regulating retinoic acid levels, a known morphogen.
- Absence of CYP1B1 is linked to primary congenital glaucoma, indicating its role in tissue differentiation.
Conclusions:
- Embryonic CYP forms likely metabolize endogenous substrates to support morphogenesis.
- CYP enzymes regulate morphogen gradients, influencing cell differentiation and tissue development.
- Further research is needed to elucidate the specific morphogens regulated by CYP1B1 and its precise role in development.
Related Concept Videos
01:17Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
01:14Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:25Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...